Duality Biotherapeutics, Inc.（09606.HK）股價、圖表、新聞與AI分析

Q: DUALITYBIO-B 股票的價格表現如何？

DUALITYBIO-B 的當前價格為 $359，在上個交易日 下降 了 1.04%。

Q: Duality Biotherapeutics, Inc. 的主要業務主題或行業是什麼？

Duality Biotherapeutics, Inc. 屬於 Biotechnology 行業，該板塊是 Health Care

Q: Duality Biotherapeutics, Inc. 的市值是多少？

Duality Biotherapeutics, Inc. 的當前市值是 $31.6B

首頁

股票

09606.HK

DUALITYBIO-B (09606.HK)

Duality Biotherapeutics, Inc.

HK$359

-1.04%

$-3.8

休市： Jan 16, 16:00:00 HKT

關鍵數據

前收市價

$362.8

開盤價

$362.8

當日範圍

$351.8 - $364.8

52週區間

$165.5 - $563.5

交易量

689.5K

平均成交量

1.2M

每股盈餘 (TTM)

-35.81

股息收益率

市值

$31.6B

什麼是 DUALITYBIO-B？

Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.

功能特性

交易策略